Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03596281
Title Pembrolizumab in Combination With Bevacizumab and Pegylated Liposomal Doxorubicin in Patients With Ovarian Cancer (PEMBOV)
Recruitment Active, not recruiting
Gender female
Phase Phase I
Variant Requirements No
Sponsors Gustave Roussy, Cancer Campus, Grand Paris
Age Groups: adult | senior
Covered Countries FRA

Facility Status City State Zip Country Details
Gustave Roussy Villejuif Val De Marne 94805 France Details
*Shaded cells indicate that there was no data available from for the field